EP3133070
ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.11.2010EP published:
14.8.2019EP application number:
16175117.7
EPO information:
European Patent Register
Max expiry date:
23.11.2030
Title:
ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT
Timeline
Today
24.11.2010EP application
14.8.2019EP Publication
Owner
Name:
Genzyme CorporationAddress:
50 Binney Street, 02142, Cambridge, MA, US
Inventor
Name:
LIU, HanlanAddress:
Lexington, MA, US
Name:
WILLIS, ChrisAddress:
Southborough, MA, US
Name:
BHARDWAJ, RenuAddress:
Ashland, MA, US
Name:
COPELAND, Diane P.Address:
Billerica, MA, US
Name:
HARIANAWALA, AbizerAddress:
Acton, MA, US
Name:
SKELL, JeffreyAddress:
Westborough, MA, US
Name:
MARSHALL, JohnAddress:
Bridgewater, NJ, US
Name:
KOCHLING, JianmeiAddress:
Wellesley, MA, US
Name:
PALACE, GerardAddress:
Framingham, MA, US
Name:
PETERSCHMITT, JudithAddress:
Watertown, MA, US
Name:
SIEGEL, CraigAddress:
Woburn, MA, US
Name:
CHENG, SengAddress:
Natick, MA, US
Priority
Number:
264748 PDate:
27.11.2009Country:
US
Classification
Categories:
C07D 405/06, A61K 45/06, A61K 31/4025, A61P 35/00